Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest

Molecular and Cellular Biology

Volumn 28, Issue 24, 2008, Pages 7286-7295

  Acosta, Juan C ^a,e   Ferrándiz, Nuria ^a   Bretones, Gabriel ^a   Torrano, Verónica ^a   Blanco, Rosa ^a   Richard, Carlos ^b   O'Connell, Brenda ^c   Sedivy, John ^c   Delgado, M Dolores ^a   León, Javier ^a,d  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MYC PROTEIN; PROTEIN MAD1; PROTEIN P27; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR NF E2;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROID CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ERYTHROPOIESIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; K562 CELLS; LEUKEMIA; MICE; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION FACTORS;

EID: 57349150176     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00752-08     Document Type: Article

References (59)

1. Adhikary, S., and M. Eilers. 2005. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell. Biol. 6:635-645.
2. Anguita, E., J. Hughes, C. Heyworth, G. A. Blobel, W. G. Wood, and D. R. Higgs. 2004. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J. 23:2841-2852.
3. Arvanitis, C., and D. W. Felsher. 2005. Conditionally MYC: insights from novel transgenic models. Cancer Lett. 226:95-99.
4. Bar-Ner, M., L. T. Messing, C. M. Cultraro, M. J. Birrer, and S. Segal. 1992. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. Cell Growth Differ. 3:183-190.
5. Baudino, T. A., and J. L. Cleveland. 2001. The Max network gone mad. Mol. Cell. Biol. 21:691-702.
6. 1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 15:1347-1356.
7. Bouchard, C., K. Thieke, A. Maier, R. Saffrich, J. Hanley-Hyde, W. Ansorge, S. Reed, P. Sicinski, J. Bartek, and M. Eilers. 1999. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18:5321-5333.
8. Coppola, J. A., and M. D. Cole. 1986. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature 320:760-763.
9. Cowling, V. H., and M. D. Cole. 2006. Mechanism of transcriptional activation by the Myc oncoproteins. Semin. Cancer Biol. 16:242-252.
10. Cultraro, C. M., T. Bino, and S. Segal. 1997. Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation. Mol. Cell. Biol. 17:2353-2359.
11. Dang, C. V., A. O'Donnell, K., K. I. Zeller, T. Nguyen, R. C. Osthus, and F. Li. 2006. The c-Myc target gene network. Semin. Cancer Biol. 16:253-264.
12. Delgado, M. D., A. Lerga, M. Canelles, M. T. Gomez-Casares, and J. Leon. 1995. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene 10:1659-1665.
13. WAF1-dependent mechanism. Oncogene 19:783-790.
14. Denicourt, C., and S. F. Dowdy. 2004. Cip/Kip proteins: more than just CDKs inhibitors. Genes Dev. 18:851-855.
15. Kip1. Blood 99:2199-2206.
16. Dmitrovsky, E., W. M. Kuehl, G. F. Hollis, I. R. Kirsch, T. P. Bender, and S. Segal. 1986. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature 322:748-750.
17. Eisenman, R. N. 2001. Deconstructing myc. Genes Dev. 15:2023-2030.
18. Fernandez, P. C., S. R. Frank, L. Wang, M. Schroeder, S. Liu, J. Greene, A. Cocito, and B. Amati. 2003. Genomic targets of the human c-Myc protein. Genes Dev. 17:1115-1129.
19. Ferreira, R., K. Ohneda, M. Yamamoto, and S. Philipsen. 2005. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol. Cell. Biol. 25:1215-1227.
20. Freytag, S. O., C. V. Dang, and W. M. Lee. 1990. Definition of the activities and properties of c-myc required to inhibit cell differentiation. Cell Growth Differ. 1:339-343.
21. Grandori, C., S. M. Cowley, L. P. James, and R. N. Eisenman. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16:653-699.
22. Habib, T., H. Park, M. Tsang, I. M. de Alboran, A. Nicks, L. Wilson, P. S. Knoepfler, S. Andrews, D. J. Rawlings, R. N. Eisenman, and B. M. Iritani. 2007. Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. J. Cell Biol. 179:717-731.
23. Herold, S., M. Wanzel, V. Beuger, C. Frohme, D. Beul, T. Hillukkala, J. Syvaoja, H. P. Saluz, F. Haenel, and M. Eilers. 2002. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol. Cell 10:509-521.
24. Hurlin, P. J., C. Queva, and R. N. Eisenman. 1997. Mnt, a novel Maxinteracting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 11:44-58.
25. Kitagawa, M., H. Higashi, H. K. Jung, I. Suzuki-Takahashi, M. Ikeda, K. Tamai, J. Kato, K. Segawa, E. Yoshida, S. Nishimura, and Y. Taya. 1996. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:7060-7069.
26. Li, C., and W. H. Wong. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98:31-36.
27. Li, Z., S. Van Calcar, C. Qu, W. K. Cavenee, M. Q. Zhang, and B. Ren. 2003. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. USA 100:8164-8169.
28. Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified estrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
29. Lu, S. J., S. Rowan, M. R. Bani, and Y. Ben-David. 1994. Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression. Proc. Natl. Acad. Sci. USA 91:8398-8402.
30. Lutz, W., J. Leon, and M. Eilers. 2002. Contributions of Myc to tumorigenesis. Biochim. Biophys. Acta 1602:61-71.
31. Cip1 decreases survival and synergizes with MYC in murine lymphomagenesis. EMBO J. 21:3739-3748.
32. Mauleon, I., M. N. Lombard, M. J. Munoz-Alonso, M. Canelles, and J. Leon. 2004. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: differential regulation of mad family and stress-mediated induction of c-myc. Mol. Carcinog. 39:85-90.
33. KIP1 cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity. Mol. Cell. Biol. 22:3014-3023.
34. 1 phase progression. Landes Bioscience, New York, NY.
35. Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J. Biol. Chem. 280:18120-18129.
36. Nesbit, C. E., J. M. Tersak, and E. V. Prochownik. 1999. MYC oncogenes and human neoplastic disease. Oncogene 18:3004-3016.
37. Obaya, A. J., and J. M. Sedivy. 2002. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol. Life Sci. 59:126-142.
38. Okita, K., T. Ichisaka, and S. Yamanaka. 2007. Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
39. Orian, A., B. van Steensel, J. Delrow, H. J. Bussemaker, L. Li, T. Sawado, E. Williams, L. W. Loo, S. M. Cowley, C. Yost, S. Pierce, B. A. Edgar, S. M. Parkhurst, and R. N. Eisenman. 2003. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17:1101-1114.
40. Oster, S. K., C. S. Ho, E. L. Soucie, and L. Z. Penn. 2002. The myc oncogene: MarvelouslY Complex. Adv. Cancer Res. 84:81-154.
41. Patel, J. H., A. P. Loboda, M. K. Showe, L. C. Showe, and S. B. McMahon. 2004. Analysis of genomic targets reveals complex functions of MYC. Nat. Rev. Cancer 4:562-568.
42. Penn, L. J., M. W. Brooks, E. M. Laufer, and H. Land. 1990. Negative autoregulation of c-myc transcription. EMBO J. 9:1113-1121.
43. Cip1. EMBO J. 18:5310-5320.
44. Prochownik, E. V., and J. Kukowska. 1986. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature 322:848-850.
45. Rylski, M., J. J. Welch, Y. Y. Chen, D. L. Letting, J. A. Diehl, L. A. Chodosh, G. A. Blobel, and M. J. Weiss. 2003. GATA-1-mediated proliferation arrest during erythroid maturation. Mol. Cell. Biol. 23:5031-5042.
46. 1-phase progression. Genes Dev. 13:1501-1512.
47. Skoda, R. C., S. F. Tsai, S. H. Orkin, and P. Leder. 1995. Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice. J. Exp. Med. 181:1603-1613.
48. Kip1 cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 93:4167-4178.
49. Cip1 pathway. J. Biol. Chem. 280:1112-1122.
50. Visvader, J. E., A. G. Elefanty, A. Strasser, and J. M. Adams. 1992. GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. EMBO J. 11:4557-4564.
51. Kip1 is abrogated by c-Myc. EMBO J. 15:6595-6604.
52. Wanzel, M., S. Herold, and M. Eilers. 2003. Transcriptional repression by Myc. Trends Cell Biol. 13:146-150.
53. Wilson, A., M. J. Murphy, T. Oskarsson, K. Kaloulis, M. D. Bettess, G. M. Oser, A. C. Pasche, C. Knabenhans, H. R. Macdonald, and A. Trumpp. 2004. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18:2747-2763.
54. Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20:1688-1702.
55. Yaroslavskiy, B., S. Watkins, A. D. Donnenberg, T. J. Patton, and R. A. Steinman. 1999. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood 93:2907-2917.
56. Zanet, J., S. Pibre, C. Jacquet, A. Ramirez, I. M. de Alboran, and A. Gandarillas. 2005. Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication, and stem cell amplification. J. Cell Sci. 118:1693-1704.
57. 1/S cyclin-dependent kinases. J. Biol. Chem. 272:12738-12746.
58. Zeller, K. I., X. Zhao, C. W. Lee, K. P. Chiu, F. Yao, J. T. Yustein, H. S. Ooi, Y. L. Orlov, A. Shahab, H. C. Yong, Y. Fu, Z. Weng, V. A. Kuznetsov, W. K. Sung, Y. Ruan, C. V. Dang, and C. L. Wei. 2006. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. USA 103:17834-17839.
59. Kip1 coordinately regulate cerebellar development. Proc. Natl. Acad. Sci. USA 103:11579-11583.